Shilpa Medicare Limited (BOM:530549)
1,063.65
+17.90 (1.71%)
At close: Oct 1, 2026
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 208.03 billion as of October 2, 2026. Its market cap has increased by 181.97% in one year.
Market Cap
208.03B
Enterprise Value
214.18B
Revenue
16.83B
Ranking
n/a
PE Ratio
69.99
Stock Price
1,063.65
ChartMarket Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 208.03B, an increase of 461,191.68%. That is a compound annual growth rate of 36.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 208.03B | 231.15% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 274.51B |
| Suven Life Sciences | 91.92B |
| Symbiotec Pharmalab | 73.52B |
| IOL Chemicals and Pharmaceuticals | 59.12B |
| Gujarat Themis Biosyn | 52.63B |
| NGL Fine-Chem | 17.77B |
| Bajaj HealthCare | 11.26B |
| Shree Ganesh Remedies | 8.57B |